Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MDM2 | Q00987 | 5/20 | 0.41 |
| ▸ | CETP | P11597 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 3/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.33 |
| ▸ | KDR | P35968 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8540705 | 0.92 | MDM2 (0.45) | MDM2LMNAMAPTMEN1KMT2A | |
| SCHEMBL8546091 | 0.92 | MDM2 (0.42) | MDM2CETPMAPTMEN1KMT2A | |
| SCHEMBL8538965 | 0.91 | MDM2 (0.46) | MDM2LMNAMEN1KMT2AALDH1A1 | |
| SCHEMBL8545611 | 0.87 | MDM2 (0.41) | MDM2LMNAMAPTALDH1A1NPSR1 | |
| SCHEMBL8547263 | 0.85 | MDM2 (0.42) | MDM2LMNAMAPTMEN1KMT2A | |
| SCHEMBL8544760 | 0.83 | MDM2 (0.42) | MDM2CETPMAPTMEN1KMT2A | |
| SCHEMBL8541906 | 0.82 | MDM2 (0.44) | MDM2LMNAMEN1KMT2AALDH1A1 | |
| SCHEMBL8540741 | 0.82 | MDM2 (0.38) | MDM2CETPMAPTMEN1KMT2A | |
| SCHEMBL8543993 | 0.81 | MDM2 (0.45) | MDM2LMNAMAPTALDH1A1 | |
| SCHEMBL8541130 | 0.81 | MDM2 (0.43) | MDM2LMNAMEN1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0483881-B1 | 3-Amidoindolyl derivatives | MERRELL PHARMA INC (US) | 1998-01-21 | — | — | EP | disclosed |
| US-5703107-A | CENTRAL NERVOUS SYSTEM DISORDERS; ANALGESICS; ANTIEPILEPTIC AGENTS | MERRELL PHARMACEUTICALS INC. (US) | 1997-12-30 | — | — | US | disclosed |
| US-5675018-A | 3-amidoindolyl derivatives | MERRELL PHARMACEUTICALS INC. (US) | 1997-10-07 | — | — | US | disclosed |
| US-5491153-A | 3-amidoindolyl derivative | MERRELL DOW PHARMACEUTICALS INC. (US) | 1996-02-13 | — | — | US | disclosed |
| US-5189054-A | 3-amidoindolyl derivatives and pharmaceutical compositions thereof | MERRELL DOW PHARMACEUTICALS INC. (US) | 1993-02-23 | — | — | US | disclosed |
| EP-0483881-A1 | 3-Amidoindolyl derivatives | MERRELL PHARMACEUTICALS INC. (US) | 1992-05-06 | — | — | EP | disclosed |